Biothera Pharmaceuticals, Inc. logo — company profile

Biothera Pharmaceuticals, Inc.

Founded 1997 United States Eagan, United States 51 employees Series Unknown Biotechnology, Medical Devices

General Information

Company Name Biothera Pharmaceuticals, Inc.
Founded Year 1997
Location United States Eagan, United States +1
Employees 51
Industries Biotechnology, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Biothera Pharmaceuticals, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Biothera Pharmaceuticals, Inc.

Biothera Pharmaceuticals, Inc. is a US-based privately held, clinical stage immuno-oncology company that focuses on developing Imprime PGG, their proprietary immunotherapy, in combination with immune checkpoint inhibitors (CPIs) for various cancer indications. Imprime PGG is a biologic innate immune modulator known for activating the immune system and coordinating anti-cancer immune responses, resulting in increased activation of cancer-specific T cells. The company has established clinical research agreements with Merck, Genentech, and AstraZeneca to assess Imprime PGG in combination with CPIs for multiple cancer indications, including metastatic triple negative breast cancer, head and neck cancer, and colorectal cancer. Promisingly, Imprime PGG has demonstrated strong evidence of tolerability in clinical trials involving more than 500 subjects, including over 400 cancer patients. Founded in 1997, Biothera Pharmaceuticals operates within the Biotechnology and Medical Devices industries. For more information, visit their website at www.biothera.com.

No funding data available for Biothera Pharmaceuticals, Inc. yet.

Get notified when Biothera Pharmaceuticals, Inc. raises funding

Biothera Pharmaceuticals, Inc. Alternatives & Competitors

Biothera Pharmaceuticals, Inc. vs
IMV Inc.
IMV Inc. Canada

Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and h...

Post Ipo Equity
18 employees
Biotechnology, Health Care
Biothera Pharmaceuticals, Inc. vs
Memgen, Inc.
Memgen, Inc. United States

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Series Unknown
7 employees
Biotechnology, Health Care
Biothera Pharmaceuticals, Inc. vs

ImmuNext develops compounds on the cutting edge of immunotherapy for cancer and autoimmune diseases....

4 employees
Biotechnology
Also compare with: Biothera Pharmaceuticals, Inc. vs Tolerx, Inc. Tolerx, Inc.

FAQ About Biothera Pharmaceuticals, Inc.

Biothera Pharmaceuticals is a privately held, clinical stage immuno-oncology company developing our proprietary immunotherapy, Imprime PGG, in combination with immune checkpoint inhibitors, or CPIs, for multiple cancer indications. Imprime PGG is a biologic innate immune modulator that activates the...
Biothera Pharmaceuticals, Inc. was founded in 1997.
Biothera Pharmaceuticals, Inc. is headquartered in Eagan, United States.
Biothera Pharmaceuticals, Inc. operates in the following industries: Biotechnology, Medical Devices.
Biothera Pharmaceuticals, Inc. has approximately 51 employees.
Top alternatives and competitors to Biothera Pharmaceuticals, Inc. include IMV Inc., Memgen, Inc., ImmuNext, Tolerx, Inc., ALX Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biothera Pharmaceuticals, Inc. and IMV Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Biothera Pharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes